AIDX — 20/20 Biolabs, Inc.
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1139685 ·
Last close
$0.41
Market Cap
$5.22M
52W High
$50.00
52W Low
$0.40
ADV30
71,951
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 730,571 | 304,727 | -1,244,223 | -1,506,343 | 6,123,185 | 4,546,140 | 4,502,485 |
| Mar 2026 | 353,375 | 62,884 | -1,443,356 | -2,174,836 | 5,803,347 | 4,219,099 | 3,046,222 |
| Dec 2025 | 538,274 | 130,417 | -912,846 | -1,307,771 | 4,137,357 | 1,025,987 | 4,156,582 |
| Sep 2025 | — | — | — | — | 3,239,449 | 1,144,855 | 3,130,993 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-2,825,371
Investing CF
$-5,354
Financing CF
$5,252,589
CapEx
$-5,354
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.35
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-35,422,055
Inventory
$104,523
Receivables
$201,481
ST Investments
—
EBIT TTM
$-5,103,499
Pretax Income TTM
$-5,496,232
Interest Exp TTM
$392,733
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,040,199
EBITDA
$-4,321,660
Free Cash Flow
$-805,684
Enterprise Value
$4,716,285
Total Cash
$4,546,140
Total Debt
$572,448
Shares Out
12,770,303
Trailing EPS
$-0.58
Book Value
$0.13
ROE
-331.2%
ROA
-62.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,045,133 | -3,330,871 | -3,738,821 | 4,140,000 | 4,156,582 | -19,225 | -1,919,720 |
| Dec 2024 | 1,752,343 | -5,661,057 | -5,551,667 | 3,580,000 | 2,078,926 | 1,505,482 | -2,598,785 |
| Dec 2023 | 1,424,304 | -6,361,462 | -6,391,309 | 6,367,828 | 2,080,336 | 4,287,492 | -4,479,971 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| OBULF | One Bullion Ltd | $5.21M | $0.26 | — |
| SFHG | SAMFINE CREATION HOLDINGS GROUP Ltd | $5.20M | $2.30 | — |
| ELVG | Elvictor Group, Inc. | $5.25M | $6.30 | — |
| POLA | Polar Power, Inc. | $5.31M | $1.26 | — |
| RSCF | REFLECT SCIENTIFIC, INC. | $5.14M | $0.06 | — |
News headlines (Yahoo Finance, 1h cache)
20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
2026-08-26 12:31 · Yahoo
20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour
2026-07-30 12:31 · Yahoo
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy
2026-07-27 20:30 · Yahoo
20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month
2026-06-22 20:45 · Yahoo
20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters
2026-05-27 12:31 · Yahoo
20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress
2026-05-20 20:05 · Yahoo
20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026
2026-05-14 12:31 · Yahoo
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock
2026-07-23 12:31 · Yahoo
20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth
2026-07-09 20:01 · Yahoo
Profound Medical Stock And 2 Canadian AI Healthcare Stocks To Watch
2026-09-06 02:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.